...
机译:从两个3期临床分析EQ-5D分数试验romiplostim治疗免疫
Amgen Inc., Thousand Oaks, CA, United States;
Servicio de Hematologia, Hospital Universitario La Fe, Avenida Campanar 21, Valencia 46009, Spain;
Mount Sinai School of Medicine, New York, NY, United StatesHealth Outcomes Solutions, Winter Park, FL, United States;
romiplostim; EuroQOL Questionnaire; Clinical Trial, Phase IIIImmune Thrombocytopenia;
机译:Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
机译:Pharmacokinetics, Safety, and Pharmacodynamics of Romiplostim in Chinese Subjects With Immune Thrombocytopenia: A Phase I/II Trial
机译:A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
机译:romiplostim治疗免疫性血小板减少症(ITP)的两项3期临床试验的EQ-5D得分分析